Connect with others who understand.

sign up Log in
About MyHemophiliaTeam
Powered By

Vonvendi is approved by the Food and Drug Administration (FDA) for on-demand treatment and control of bleeding episodes in adults with von Willebrand disease. The technical name of Vonvendi is von Willebrand factor (recombinant).

Vonvendi is a clotting factor. Clotting factors work by supplying proteins missing in people with bleeding disorders.

How do I take it?
Prescribing information states that Vonvendi is given as an intravenous injection.

Vonvendi comes as a powder that must be reconstituted before injection.

Side effects
The FDA-approved label for Vonvendi lists common side effects including itching.

Rare but serious side effects listed for Vonvendi include life-threatening hypersensitivity reactions, thromboembolic events (dangerous blood clots), and the development of inhibitors.

For more details about this treatment, visit:

Treatment of Hemophilia – Hemophilia Federation of America

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in